Anatomic Pathology Testing Market by Component (Consumables, Instruments, Services), Application (Disease Diagnosis, Drug Discovery & Development) - Global Forecast 2024-2030
The Anatomic Pathology Testing Market size was estimated at USD 42.43 billion in 2023 and expected to reach USD 45.03 billion in 2024, at a CAGR 6.22% to reach USD 64.74 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Anatomic Pathology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anatomic Pathology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Anatomic Pathology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Danaher Corporation, Diapath S.p.A., Digipath, Inc., Enzo Biochem, Inc., Epic Sciences, Epredia, F. Hoffmann-La Roche AG, Hologic, Inc., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Sakura Finetek USA, Inc..
Market Segmentation & Coverage
This research report categorizes the Anatomic Pathology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Component
Consumables
Instruments
Services
Application
Disease Diagnosis
Drug Discovery & Development
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom The report offers valuable insights on the following aspects:
Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
What is the market size and forecast of the Anatomic Pathology Testing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anatomic Pathology Testing Market?
What are the technology trends and regulatory frameworks in the Anatomic Pathology Testing Market?
What is the market share of the leading vendors in the Anatomic Pathology Testing Market?
Which modes and strategic moves are suitable for entering the Anatomic Pathology Testing Market?
Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Anatomic Pathology Testing Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the number of clinical trials pertaining to cancer drugs due to changes in food habits and lifestyle
5.1.1.2. Increasing focus on personalized medicine
5.1.1.3. Surge in demand to improve the diagnostic procedure in clinical centers
5.1.2. Restraints
5.1.2.1. Unavailability of skilled professionals
5.1.3. Opportunities
5.1.3.1. Advances in anatomic pathology testing providing targeted coverage
5.1.3.2. Growth in reliance on biomarkers-based pathology tests and procedures for exploring malignancy and tumorigenesis
5.1.4. Challenges
5.1.4.1. Strigent rules and regulations by the government
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Anatomic Pathology Testing Market, by Component
6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Services
7. Anatomic Pathology Testing Market, by Application
7.1. Introduction
7.2. Disease Diagnosis
7.3. Drug Discovery & Development
8. Americas Anatomic Pathology Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Anatomic Pathology Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Anatomic Pathology Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Agilent Technologies Inc.
12.1.3. Becton, Dickinson and Company
12.1.4. Cardinal Health, Inc.
12.1.5. Danaher Corporation
12.1.6. Diapath S.p.A.
12.1.7. Digipath, Inc.
12.1.8. Enzo Biochem, Inc.
12.1.9. Epic Sciences
12.1.10. Epredia
12.1.11. F. Hoffmann-La Roche AG
12.1.12. Hologic, Inc.
12.1.13. Laboratory Corporation of America Holdings
12.1.14. Merck KGaA
12.1.15. Quest Diagnostics Incorporated
12.1.16. Sakura Finetek USA, Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
FIGURE 1. ANATOMIC PATHOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 2. ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2023 VS 2030